Form 4 for FLO FLOWERS FOODS INC
Accepted 2024-05-28 00:00:00 ET · period of report 2024-05-23 · accession 0001127602-24-016648 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-28 | 2024-05-23 | FLO | McFadden William Jameson | Dir | M - OptEx | $0.00 | +5,940 | 523.7K | +1% | $0 |
| D | 2024-05-28 | 2024-05-23 | FLO | McFadden William Jameson | Dir | M - OptEx | $0.00 | -5,940 | 0 | -100% | $0 |
| D | 2024-05-28 | 2024-05-23 | FLO | McFadden William Jameson | Dir | A - Grant | $0.00 | +6,570 | 6,570 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-23 | M | A | 5,940 | $0.00 | 523,695 | D | — | — | (F1) Includes 460,383 shares held in a trust, of which the reporting person is the sole beneficiary. |
| 2 | Derivative | Deferred Stock | 2024-05-23 | M | D | 5,940 | $0.00 | 0 | D | $0.00 · 2024-05-23 to — | 5,940 Common Stock | (F2) Granted under the Flowers Foods, Inc. 2014 Omnibus Equity and Incentive Compensation Plan (Amended and Restated Effective May 25, 2023). (F3) In accordance with the terms of the Flowers Foods, Inc. Deferred Shares Agreement for Directors, the deferred shares awarded do not have a conversion or exercise price. (F4) No expiration date. |
| 3 | Derivative | Deferred Stock | 2024-05-23 | A | A | 6,570 | $0.00 | 6,570 | D | $0.00 · 2025-05-22 to — | 6,570 Common Stock | (F2) Granted under the Flowers Foods, Inc. 2014 Omnibus Equity and Incentive Compensation Plan (Amended and Restated Effective May 25, 2023). (F3) In accordance with the terms of the Flowers Foods, Inc. Deferred Shares Agreement for Directors, the deferred shares awarded do not have a conversion or exercise price. (F4) No expiration date. |